Apple orders even more Apple A15 Bionic SoCs in anticipation of strong iPhone 13 demand

According to DigiTimes, Apple has increased orders for Apple A15 Bionic SoCs for its latest iPhone 13 series from Taiwan Semiconductor Manufacturing Co. (TSMC) by slashing orders for older platforms. Apple still sells the iPhone 12, iPhone 12 mini, iPhone 11, and iPhone SE 2. The company discontinued the iPhone XR, iPhone 12 Pro, and iPhone 12 Pro Max when it launched the iPhone 13 line in September.

According to Nikkei Asia, buyers of the new iPhone 13 are forced to accept longer-than-expected delivery times due to supply chain disruptions caused by the coronavirus pandemic in Vietnam, where camera module components are assembled for all four iPhone 13 models. Sources told Nikkei. that the disruptions may end by mid-October.

The iPhone 13 uses Apple's A15 Bionic SoC, which is manufactured using TSMC's advanced 5nm process. This provides energy efficiency and performance improvements over the 5nm Apple A14 Bionic platform used in the iPhone 12.

The previous A13 Bionic SoC, which was used in the iPhone 11, was manufactured using TSMC's N7P technology node. The number of transistors in the Apple A13 Bionic, A14 Bionic and A15 Bionic has grown from 8.5 to 11.8 billion and to 15 billion, respectively.

Post a Comment